US2005049306A1PendingUtilityA1
Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same
Priority: Dec 20, 2000Filed: Sep 13, 2004Published: Mar 3, 2005
Est. expiryDec 20, 2020(expired)· nominal 20-yr term from priority
C07C 39/23C07C 39/14A61K 8/347C07C 49/83A61Q 11/00
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An antimicrobial compound, composition containing such compound, and method of use of the same for reducing the presence of microorganism on a substrate or in a fluid environment comprising an antimicrobial effective carrier and one or more essential antimicrobial compounds including non-halogenated naphthol compounds.
Claims
exact text as granted — not AI-modified1 . An antimicrobial composition comprising an effective amount of at least one antimicrobial agent having the Formula:
wherein
one of R 1 and R 2 is hydroxyl, and the other of R 1 and R 2 , and each of R 3 , R 4 , and R 5 are independently selected from the group consisting of hydrogen; hydroxyl; an alkyl group optionally phenyl in which the phenyl may be substituted with a member selected from the group consisting of an alkyl group optionally substituted with hydroxyl and a cycloalkyl group optionally substituted with hydroxyl; a cycloalkyl group optionally substituted with hydroxyl; phenyl; phenyl substituted with a member selected from the group consisting of an alkyl group optionally substituted with hydroxyl, a cycloalkyl group optionally substituted with hydroxyl, and an alkoxy group; and
wherein R x is a member selected from the group consisting of an alkyl group, benzyl, and phenyl;
and each of R 6 and R 7 are selected from the group consisting of straight chain or branched alkyl optionally substituted with hydroxyl, and benzyl or phenyl optionally substituted with hydroxyl, alkyl, or alkoxy groups;
with the proviso that:
when R 1 is hydroxyl, then R 2 , R 3 , R 4 , and R 5 are not all hydrogen;
when R 2 is hydroxyl, then R 1 , R 3 , R 4 , and R 5 are not all hydrogen;
when R 1 is hydroxyl, and each of R 3 and R 5 is hydrogen, then R 2 and R 4 are not independently selected from methyl and hydrogen;
when R 2 is hydroxyl, and each of R 1 , R 3 , R 4 is hydrogen, then R 5 is not methyl;
when R 1 is hydroxyl, and each of R 3 , R 4 and R 5 is hydrogen, then R 2 is not isobutyl; and
when R 2 is hydroxyl and each of R 3 , R 4 , and R 5 is hydrogen, then R 1 is not selected from the group consisting of isopropyl and isobutyl; and
an antimicrobial effective carrier.
2 . The antimicrobial composition of claim 1 wherein the antimicrobial effective carrier is selected from the group consisting of water, saline, alcohol, glycerine, propylene glycol, mineral oil, petrolatum, and mixtures thereof.
3 . The antimicrobial composition of claim 1 wherein the compound has the formula (IIa) wherein each of R 3 , R 4 , and R 5 is hydrogen.
4 . The antimicrobial composition of claim 3 wherein R 1 is hydroxyl.
5 . The antimicrobial composition of claim 4 wherein R 2 is an alkyl group.
6 . The antimicrobial composition of claim 5 wherein R 2 is tert-butyl.
7 . The antimicrobial composition of claim 3 wherein R 2 is hydroxyl.
8 . The antimicrobial composition of claim 7 wherein R 1 is selected from the group consisting of an alkyl group optionally substituted with hydroxyl, a cycloalkyl group optionally substituted with hydroxyl, a phenyl group optionally substituted with hydroxyl, and benzyl.
9 . The antimicrobial composition of claim 8 wherein R 1 is selected from the group consisting of isopropyl, butyl, tert-butyl, hexyl, cyclohexyl, phenyl and benzyl.
10 . The antimicrobial composition of claim 1 wherein the compound has the formula (IIa) wherein R 1 is hydroxyl, and R 3 and R 5 are each hydrogen.
11 . The antimicrobial composition of claim 10 wherein R 2 is hydrogen and R 4 is an alkyl group optionally substituted with phenyl.
12 . The antimicrobial composition of claim 11 wherein R 4 is selected from the group consisting of tert-butyl and benzyl.
13 . The antimicrobial composition of claim 10 wherein each of R 2 and R 4 is tert-butyl.
14 . The antimicrobial composition of claim 1 wherein the compound has the formula (IIa) wherein each of R 1 , R 4 , and R 5 is hydrogen, and R 3 is selected from the group consisting of an alkyl group and an alkenyl group.
15 . The antimicrobial composition of claim 14 wherein R 3 is isopropyl.
16 . The antimicrobial composition of claim 8 wherein R 1 is selected from the group consisting of 2-hydroxycyclohexyl, 3-hydroxycyclohexyl, 4-hydroxycyclohexyl, 2-hydroxycyclopentyl, 3-hydroxycyclopentyl, 4-hydroxycyclopentyl, 2-hydroxycyclophenyl, 3-hydroxycyclophenyl, and 4-hydroxycyclophenyl
17 . The antimicrobial composition of claim 4 wherein R 2 is selected from the group consisting of 2-hydroxyphenyl and 3-hydroxyphenyl.
18 . The antimicrobial composition of claim 1 wherein the compound has the formula (IIa) wherein R 2 is hydroxyl, each of R 1 and R 4 is hydrogen, R 3 is an alkyl group, and R 5 is selected from the group consisting of an alkyl group, an alkyl group substituted with phenyl, a cycloalkenyl group, and a benzyl group optionally substituted with an alkyl group.
19 . The antimicrobial composition of claim 18 wherein R 3 is isopropyl and R 5 is selected from the group consisting of 1-methyl-butyl, 1-phenyl-ethyl, cyclohex-2-enyl, 1-ethyl-1-methyl-propyl, and 3-methyl-benzyl.
20 . The antimicrobial composition of claim 1 wherein the compound has the formula (IIa) wherein R 2 is hydroxyl, each of R 3 and R 4 is hydrogen, R 1 is an alkyl group, and R 5 is selected from the group consisting of an alkyl group and a benzyl group optionally substituted with an alkyl group.
21 . The antimicrobial composition of claim 20 wherein R 1 is isopropyl, and R 5 is selected from the group consisting of 1-ethyl-1-methyl-propyl, 3-methyl-benzyl, and tert-butyl.
22 . The antimicrobial composition of claim 1 wherein the antimicrobial agent is selected from the group consisting of 3-isopropyl-6-(1-methyl-butyl)-naphthalen-2-ol, 3-isopropyl-6-(1-phenyl-ethyl)-naphthalen-2-ol, 1-(4-hydroxynaphthyl)octan-1-one, 6-(1-ethyl-1-methyl-propyl)-1-isopropyl-naphthalen-2-ol, 6-(tert-butyl)-1-isoproyl-naphthalen-2-ol, 6-(3-cyclohexenyl)-2-naphthol, 1-(6-hydroxy-2-naphthyl)hexan-1-one, 1-isopropyl-6-(3-methyl-benzyl)-naphthalen-2-ol, 1-(4-hydroxynaphthyl)hexan-1-one, 6-cyclohex-2-enyl-3-isopropyl-naphthalen-2-ol, 6-cyclopentyl-2-naphthol, 6-(1-ethyl-1-methyl-propyl)-3-isopropyl-naphthalen-2-ol, 3-isopropyl-6-(3-methyl-benzyl)naphthalen-2-ol, 6-(tert-butyl)-1-isopropyl-naphthalen-2-ol, 6-(3-methyl-benzyl)-2-naphthol, 4-(2-hydroxycyclohexyl)-1-naphthol, 4-(3-hydroxycyclohexyl)-1-naphthol, 1-(2-hydroxycyclohexyl)-2-naphthol, 1-(3-hydroxycyclohexyl)-2-naphthol, 1-(4-hydroxycyclohexyl)-2-naphthol, 1-cyclopentyl-2-naphthol, 1-(2-hydroxycyclopentyl)-2-naphthol, 1-(3-hydroxycyclopentyl)-2-naphthol, 4-(2-hydroxycyclopentyl)-1-naphthol, and 4-(3-hydroxycyclopentyl)-1-naphthol.
23 . The antimicrobial composition of claim 1 wherein the antimicrobial effective amount is from about 0.0001% to 10.0% by weight based on the total weight of the antimicrobial composition.
24 . The antimicrobial composition of claim 23 wherein the antimicrobial effective amount is from about 0.001% to 5.0% by weight.
25 . An oral composition comprising an antimicrobial effective amount of at least one antimicrobial agent having the Formula
wherein
one of R 1 and R 2 is hydroxyl, and the other of R 1 and R 2 , and each of R 3 , R 4 , and R 5 are independently selected from the group consisting of hydrogen; hydroxyl; an alkyl group optionally substituted with hydroxyl; an alkenyl group; a cycloalkenyl group; an alkyl group substituted with phenyl in which the phenyl may be substituted with a member selected from the group consisting of an alkyl group optionally substituted with hydroxyl and a cycloalkyl group optionally substituted with hydroxyl; a cycloalkyl group optionally substituted with hydroxyl; phenyl; phenyl substituted with a member selected from the group consisting of an alkyl group optionally substituted with hydroxyl, a cycloalkyl group optionally substituted with hydroxyl, and an alkoxy group; and
wherein R x is a member selected from the group consisting of an alkyl group, benzyl, and phenyl;
and each of R 6 and R 7 are selected from the group consisting of straight chain or branched alkyl optionally substituted with hydroxyl, and benzyl or phenyl optionally substituted with hydroxyl, alkyl, or alkoxy groups;
with the proviso that:
when R 1 is hydroxyl, then R 2 , R 3 , R 4 , and R 5 are not all hydrogen;
when R 2 is hydroxyl, then R 1 , R 3 , R 4 , and R 5 are not all hydrogen; and
an orally acceptable carrier.
26 . The oral composition of claim 25 , wherein the orally acceptable carrier is selected from the group consisting of water, saline, alcohol, glycerine, propylene glycol, and mixtures thereof.
27 . The oral composition of claim 25 wherein the compound has the formula (IIIa) wherein each of R 3 , R 4 , and R 5 is hydrogen.
28 . The oral composition of claim 27 wherein R 1 is hydroxyl.
29 . The oral composition of claim 28 wherein R 2 is an alkyl group.
30 . The oral composition of claim 29 wherein R 2 is tert-butyl.
31 . The oral composition of claim 27 wherein R 2 is hydroxyl.
32 . The oral composition of claim 31 wherein R 1 is selected from the group consisting of an alkyl group, a cycloalkyl group optionally substituted with hydroxyl, phenyl optionally substituted with hydroxyl, and benzyl.
33 . The oral composition of claim 32 wherein R 1 is selected from the group consisting of isopropyl, butyl, tert-butyl, hexyl, cyclohexyl, phenyl and benzyl.
34 . The oral composition of claim 25 wherein the compound has the formula (IIIa) wherein R 1 is hydroxyl, and R 3 and R 5 are each hydrogen.
35 . The oral composition of claim 34 wherein R 2 is hydrogen and R 4 is an alkyl group optionally substituted with phenyl.
36 . The oral composition of claim 35 wherein R 4 is selected from the group consisting of tert-butyl and benzyl.
37 . The oral composition of claim 34 wherein each of R 2 and R 4 is tert-butyl.
38 . The oral composition of claim 25 wherein the compound has the formula (IIIa) wherein each of R 1 , R 4 , and R 5 is hydrogen, R 2 is hydroxyl and R 3 is an alkyl group.
39 . The oral composition of claim 38 wherein R 3 is isopropyl.
40 . The oral composition of claim 32 wherein R 1 is selected from the group consisting of 2-hydroxycyclohexyl, 3-hydroxycyclohexyl, 4-hydroxycyclohexyl, 2-hydroxycyclopentyl, 3-hydroxycyclopentyl, cyclopentyl, 2-hydroxyphenyl, 3-hydroxyphenyl, and 4-hydroxyphenyl.
41 . An oral composition of claim 25 wherein the compound has the formula (IIIa) wherein R 1 is hydroxyl, each of R 3 , R 4 , and R 5 is hydrogen, and R 2 is selected from the group consisting of 2-hydroxyphenyl and 3-hydroxyphenyl.
42 . The oral composition of claim 25 wherein the compound has the formula (IIIa) wherein R 2 is hydroxyl, each of R 1 and R 4 is hydrogen, R 3 is an alkyl group, and R 5 is selected from the group consisting of an alkyl group, an alkyl group substituted with phenyl, a cycloalkenyl group, and benzyl substituted with an alkyl group.
43 . The oral composition of claim 42 wherein R 3 is isopropyl and R 5 is selected from the group consisting of 1-methyl-butyl, 1-phenyl-ethyl, cyclohex-2-enyl, 1-ethyl-1-methyl-propyl, and 3-methyl-benzyl.
44 . The oral composition of claim 25 wherein the compound has the formula (IIIa) wherein R 2 is hydroxyl, each of R 3 and R 4 is hydrogen, R 1 is an alkyl group, and R 5 is selected from the group consisting of an alkyl group and benzyl substituted with an alkyl group.
45 . The oral composition of claim 44 wherein R 1 is isopropyl, and R 5 is selected from the group consisting of 1-ethyl-1-methyl-propyl, 3-methyl-benzyl, and tert-butyl.
46 . The oral composition of claim 25 wherein the antimicrobial agent is selected from the group consisting of 3-isopropyl-6-(1-methyl-butyl)-naphthalen-2-ol, 3-isopropyl-6-(1-phenyl-ethyl)-naphthalen-2-ol, 1-(4-hydroxynaphthyl)octan-1-one, 6-(1-ethyl-1-methyl-propyl)-1-isopropyl-naphthalen-2-ol, 6-(tert-butyl)-1-isoproyl-naphthalen-2-ol, 6-(3-cyclohexenyl)-2-naphthol, 1-(6-hydroxy-2-naphthyl)hexan-1-one, 1-isopropyl-6-(3-methyl-benzyl)-naphthalen-2-ol, 1-(4-hydroxynaphthyl)hexan-1-one, 6-cyclohex-2-enyl-3-isopropyl-naphthalen-2-ol, 6-cyclopentyl-2-naphthol, 6-(1-ethyl-1-methyl-propyl)-3-isopropyl-naphthalen-2-ol, 3-isopropyl-6-(3-methyl-benzyl)naphthalen-2-ol, 6-(tert-butyl)-1-isopropyl-naphthalen-2-ol, 6-(3-methyl-benzyl)-2-naphthol, 4-(2-hydroxycyclohexyl)-1-naphthol, 4-(3-hydroxycyclohexyl)-1-naphthol, 1-(2-hydroxycyclohexyl)-2-naphthol, 1-(3-hydroxycyclohexyl)-2-naphthol, 1-(4-hydroxycyclohexyl)-2-naphthol, 1-cyclopentyl-2-naphthol, 1-(2-hydroxycyclopentyl)-2-naphthol, 1-(3-hydroxycyclopentyl)-2-naphthol, 4-(2-hydroxycyclopentyl)-1-naphthol, and 4-(3-hydroxycyclopentyl)-1-naphthol.
47 . The oral composition of claim 25 wherein the antimicrobial effective amount is from about 0.0001% to 10.0% by weight based on the total weight of the antimicrobial composition.
48 . The oral composition of claim 47 wherein the antimicrobial effective amount is from about 0.001% to 5.0% by weight.
49 . The oral composition of claim 25 further comprising at least one essential oil wherein at least one essential oil is selected from the group consisting of thymol, menthol, eucalyptol, methyl salicylate, and combinations thereof.
50 . The oral composition of claim 49 wherein the essential oils comprise:
an amount of from about 0.005 to 0.5% menthol; an amount of from about 0.005 to 0.5% eucalyptol; an amount of from about 0.005 to 0.5% methyl salicylate; and an amount of from about 0.005 to 0.5% thymol.
51 . The oral composition of claim 25 further comprising an antimicrobial enhancing agent in an amount of from about 0.05% to 5% by weight.
52 . The oral composition of claim 51 wherein the antimicrobial enhancing agent includes an average molecular weight of from about 100 to about 5,000,000.
53 . The oral composition of claim 51 wherein the antimicrobial enhancing agent is an anionic polymer containing one or more delivery-enhancing groups and retention-enhancing groups.
54 . The oral composition of claim 53 wherein the antimicrobial enhancing agent is an anionic polycarboxylate.
55 . A method of reducing the presence of microorganisms on a substrate comprising treating the substrate with an antimicrobial effective amount of the antimicrobial composition of claim 1 .
56 . The method of claim 55 wherein the antimicrobial effective carrier is selected from the group consisting of water, saline, alcohol, glycerine, propylene glycol, mineral oil, petrolatum, and mixtures thereof.
57 . A method of reducing the presence of microorganisms in an oral cavity comprising administering into the oral cavity an antimicrobial effective amount of the oral composition of claim 25 .
58 . The method of claim 57 wherein the antimicrobial effective amount is from about 0.0001 to 10% by weight.
59 . The method of claim 58 wherein the antimicrobial effective amount is from about 0.001 to 5% by weight.
60 . The method of claim 59 wherein the oral composition is in the form of a member selected from the group consisting of a mouthrinse, a dentifrice, a chewing gum, a lozenge, a dispersible oral film, and an oral film forming dentifrice.
61 . Compounds of Formula
wherein
one of R 1 and R 2 is hydroxyl, and the other of R 1 and R 2 is selected from the group consisting of hydrogen, an alkyl group optionally substituted with hydroxyl, a cycloalkyl group optionally substituted with hydroxyl, and an hydroxyphenyl group;
R 3 is selected from the group consisting of hydrogen and an alkyl group optionally substituted with hydroxyl;
R 4 is selected from the group consisting of hydrogen, a C 2 to C 6 straight chain or branched alkyl group optionally substituted with hydroxyl, a hydroxycycloalkyl group, and
wherein R x is an alkyl group;
R 5 is selected from hydrogen, an alkyl group optionally substituted with hydroxyl, a cycloalkyl group, a cycloalkenyl group, an alkyl group substituted with phenyl, benzyl substituted with an alkyl group, and
wherein R x is an alkyl group;
each of R 6 and R 7 are selected from the group consisting of straight chain or branched alkyl optionally substituted with hydroxyl, and benzyl or phenyl optionally substituted with hydroxyl, alkyl, or ‘alkoxy’ groups;
with the proviso that:
when R 1 is hydroxyl, then R 2 , R 3 , R 4 , and R 5 are not all hydrogen;
when R 2 is hydroxyl, then R 1 , R 3 , R 4 , and R 5 are not all hydrogen;
when R 2 is hydroxyl, then R 5 is not methyl;
when R 2 is hydroxyl and each of R 3 , R 4 , and R 5 is hydrogen, then R 1 is not selected from the group consisting of isopropyl and isobutyl;
when R 1 is hydroxyl and each of R 3 , R 4 and R 5 is hydrogen, then R 2 is not 4-hydroxyphenyl; and
when R 1 is hydroxyl and each of R 3 , and R 5 is hydrogen, then R 2 and R 4 are not both tert-butyl;
with the further proviso that R 6 and R 7 are not both tert-butyl.
62 . The compound of claim 61 wherein the compound has the formula (Ia) wherein R 1 is hydroxyl, each of R 2 , R 3 , and R 4 is hydrogen, and R 5 is selected from the group consisting of a hydroxycycloalkyl group and
wherein Rx is an alkyl group.
63 . The compound of claim 62 wherein R 5 is selected from the group consisting of 2-hydroxycyclohexyl, 3-hydroxycyclohexyl, 4-hydroxycyclohexyl, 2-hydroxycyclopentyl, 3-hydroxycyclopentyl, and
wherein R x is selected from the group consisting of n-heptyl and n-pentyl.
64 . The compound of claim 61 wherein the compound has the formula (Ia) wherein R 2 is hydroxyl, each of R 3 , R 4 , and R 5 is hydrogen, and R 1 is selected from the group consisting of a cycloalkyl group optionally substituted with hydroxyl and an hydroxyphenyl group.
65 . The compound of claim 64 wherein R 1 is selected from the group consisting of 2-hydroxycyclohexyl, 3-hydroxycyclohexyl, 4-hydroxycyclohexyl, 2-hydroxycyclopentyl, 3-hydroxycyclopentyl, cyclopentyl, 2-hydroxyphenyl, 3-hydroxyphenyl, and 4-hydroxyphenyl.
66 . The compound of claim 61 wherein the compound has the formula (Ia) wherein R 2 is hydroxyl, each of R 1 and R 4 is hydrogen, R 3 is an alkyl group, and R 5 is selected from the group consisting of an alkyl group, an alkyl group substituted with phenyl, a cycloalkenyl group, and benzyl substituted with an alkyl group.
67 . The compound of claim 66 wherein R 3 is isopropyl and R 5 is selected from the group consisting of 1-methyl-butyl, 1-phenyl-ethyl, cyclohex-2-enyl, 1-ethyl-1-methyl-propyl, and 3-methyl-benzyl.
68 . The compound of claim 61 wherein the compound has the formula (Ia) wherein R 2 is hydroxyl, each of R 3 and R 4 is hydrogen, R 1 is an alkyl group, and R 5 is selected from the group consisting of an alkyl group and benzyl substituted with an alkyl group.
69 . The compound of claim 68 wherein R 1 is isopropyl, and R 5 is selected from the group consisting of 1-ethyl-1-methyl-propyl, 3-methyl-benzyl, and tert-butyl.
70 . The compound of claim 61 wherein the compound has the formula (Ia) wherein R 2 is hydroxyl, each of R 1 , R 3 , and R 4 is hydrogen, and R 5 is selected from the group consisting of a cycloalkenyl group, a cycloalkyl group, benzyl substituted with an alkyl group, and
wherein R x is an alkyl group.
71 . The compound of claim 70 wherein R 5 is selected from the group consisting of 3-cyclohex-2-enyl, cyclopentyl, 3-methyl-benzyl, and
wherein R x is n-pentyl.
72 . A compound of claim 60 wherein the compound has the formula (Ia) wherein R 1 is hydroxyl, each of R 3 , R 4 , and R 5 is hydrogen, and R 2 is selected from the group consisting of 2-hydroxyphenyl and 3-hydroxyphenyl.
73 . An antimicrobial composition of claim 1 wherein the antimicrobial agent has the formula (IIb) wherein R 1 is hydroxyl and R 6 and R 7 are each independently selected from the group consisting of isopropyl, tert-butyl, phenyl and benzyl.
74 . A oral composition of claim 25 wherein the antimicrobial agent has the formula (IIIb) wherein R 1 is hydroxyl and R 6 and R 7 are each independently selected from the group consisting of isopropyl, tert-butyl, phenyl and benzyl.
75 . A compound of claim 60 wherein the compound has the formula (Ib) wherein R 1 is hydroxyl and R 6 and R 7 are each independently selected from the group consisting of isopropyl, tert-butyl, phenyl and benzyl.Join the waitlist — get patent alerts
Track US2005049306A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.